← Back to all trials
Not Yet Recruiting
NCT05634226
Simple Non-invasive Breathing Device to Improve Pulmonary Flow Pusatility in Single Ventricle Post Fontan
Conditions: Single-ventricle
Sex: All
Ages: 8 Years – N/A
Phase: NA
Enrollment: 20
Sponsor: Tarek Alsaied
Summary
This is a pilot study using a novel, minimal risk, portable, hands-free oral-positive pressure device (oPEP) in patients with Fontan palliation that will examine whether using this device in both the acute and chronic phase will alter Fontan hemodynamics and create pulsatility in the Fontan circuit and thereby increasing cardiac output.
This device is easy to use and poses no significant risk to human subjects.
The investigators will measure this through echocardiographic measures including pulsatility in different aspects of the Fontan circuit including IVC, hepatic veins, the Fontan conduit, and pulmonary arteries and aortic blood flow measurements.
After demonstration of how to use the device appropriately, the investigators will have patients use the device after their clinical echocardiogram for their clinic appointment.
The investigators will ask them to use the device at home 3-4 times a day for 10-15 mins and have them return in approximately 4 weeks to have another echocardiogram done with the same measurements.
Eligibility Criteria
Inclusion Criteria:Patients with single ventricle with Fontan palliationOver the age of 8 years who would be cooperative with breathing through the oPEP deviceExclusion Criteria:Patients with Fontan palliation under the age of 8 yearsPatients who have interrupted inferior vena cavaPatients with abnormal pulmonary artery anatomy
Source: ClinicalTrials.gov (NCT05634226). StuddyBuddy aggregates publicly available trial information.